Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: July 16, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021779

« Back to Dashboard

NDA 021779 describes VENTAVIS, which is a drug marketed by Actelion Pharms Ltd and is included in one NDA. It is available from one supplier. Additional details are available on the VENTAVIS profile page.

The generic ingredient in VENTAVIS is iloprost. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the iloprost profile page.

Summary for 021779

Tradename:	VENTAVIS
Applicant:	Actelion Pharms Ltd
Ingredient:	iloprost
Patents:	0
Formulation / Manufacturing:	see details

Pharmacology for NDA: 021779

Ingredient-type	Prostaglandins I

Medical Subject Heading (MeSH) Categories for 021779

Platelet Aggregation Inhibitors
Vasodilator Agents

Suppliers and Packaging for NDA: 021779

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
VENTAVIS	iloprost	SOLUTION;INHALATION	021779	NDA	Actelion Pharmaceuticals US, Inc.	66215-302	N	66215-302-30
VENTAVIS	iloprost	SOLUTION;INHALATION	021779	NDA	Actelion Pharmaceuticals US, Inc.	66215-303	N	66215-303-30

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	SOLUTION;INHALATION			Strength	20MCG/2ML (10MCG/ML)
Approval Date:	Dec 29, 2004	TE:		RLD:	No

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	SOLUTION;INHALATION			Strength	10MCG/ML (10MCG/ML)
Approval Date:	Dec 8, 2005	TE:		RLD:	Yes

Profile for product number 003

Active Rx/OTC/Discontinued:	RX	Dosage:	SOLUTION;INHALATION			Strength	20MCG/ML (20MCG/ML)
Approval Date:	Aug 7, 2009	TE:		RLD:	Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic

Baxter

US Army

Farmers Insurance

Teva

Boehringer Ingelheim

Fish and Richardson

Daiichi Sankyo

AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.